Digital cardiac and lung disease health startup Eko Health announced it received FDA 510(k) clearance for its AI-enabled cardiac tool that helps with the early detection of low ejection fraction, a key indicator of heart failure.
Eko's Low Ejection Fraction Tool (ELEFT) is an AI-enabled tool that allows providers to detect low ejection fraction in 15 seconds during a routine exam using an Eko stethoscope.
Read more at MobiHealthNews
Summary:
Eko's low ejection fraction tool will be added to the company's cardiac early detection platform, which already includes various algorithms to inspect heart health.
-
In the News